manufacturing via Indian partners

Hemex Health develops point-of-care blood diagnostics. Its Gazelle diagnostic platform detects and quantifies blood-based conditions including sickle cell disease, beta thalassemia, and iron-related and chronic conditions, delivering quantitative biomarker data. Founded in 2016 by Patti White and Peter Galen, Gazelle has been available in over 40 countries since its 2021 introduction and is sold through full-service medical distributors.

Read more

microchip electrophoresispoint-of-care diagnosticsproduct developmentR&D